Veracyte (VCYT) Other Non-Current Liabilities (2012 - 2026)
Veracyte's (VCYT) quarterly Other Non-Current Liabilities came in at $257000.0 in Q1 2026, down 54.91% year-on-year from $570000.0 in Q1 2025, and down 83.83% quarter-over-quarter from $1.6 million in Q4 2025.
Veracyte (VCYT) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends
Veracyte has disclosed Other Non-Current Liabilities across 10 years of filings, most recently posting $257000.0 for Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $257000.0, down 54.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $257000.0 (down 54.91% YoY), and the FY2025 annual result was $1.6 million, up 286.62% from the prior year.
- Other Non-Current Liabilities came in at $257000.0 for Q1 2026 at Veracyte, down from $1.6 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $14.2 million in Q3 2024 to a low of $257000.0 in Q1 2026.
- The 5-year median for Other Non-Current Liabilities is $791000.0 (2023), against an average of $2.0 million.
- Across the five-year window, Other Non-Current Liabilities soared 1733.12% in 2024 and slumped 95.9% in 2025, its largest moves.
- Veracyte's Other Non-Current Liabilities stood at $931000.0 in 2022, then fell by 15.57% to $786000.0 in 2023, then plunged by 47.71% to $411000.0 in 2024, then jumped by 286.62% to $1.6 million in 2025, then tumbled by 83.83% to $257000.0 in 2026.
- The last three Other Non-Current Liabilities figures came in at $257000.0 (Q1 2026), $1.6 million (Q4 2025), and $583000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Veracyte | 3.91 Bn | 3.65 Bn | 101.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 257,000.00 |
| Dec 31, 2025 | 1.59 Mn |
| Sep 30, 2025 | 583,000.00 |
| Jun 30, 2025 | 573,000.00 |
| Mar 31, 2025 | 570,000.00 |
| Dec 31, 2024 | 411,000.00 |
| Sep 30, 2024 | 14.23 Mn |
| Jun 30, 2024 | 2.20 Mn |
| Mar 31, 2024 | 528,000.00 |
| Dec 31, 2023 | 786,000.00 |
| Sep 30, 2023 | 776,000.00 |
| Jun 30, 2023 | 4.86 Mn |
| Mar 31, 2023 | 791,000.00 |
| Dec 31, 2022 | 931,000.00 |
| Sep 30, 2022 | 1.15 Mn |
| Jun 30, 2022 | 2.36 Mn |
| Mar 31, 2022 | 1.38 Mn |
| Dec 31, 2021 | 5.72 Mn |
| Sep 30, 2021 | 1.89 Mn |
| Jun 30, 2021 | 4.47 Mn |